Cambridge Investment Research Advisors’s Nutanix NTNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$687K Buy
13,489
+4,224
+46% +$191K ﹤0.01% 2658
2026
Q1
$352K Sell
9,265
-447
-5% -$18.8K ﹤0.01% 3135
2025
Q4
$502K Sell
9,712
-648
-6% -$39.6K ﹤0.01% 2715
2025
Q3
$771K Buy
10,360
+307
+3% +$22.5K ﹤0.01% 2270
2025
Q2
$768K Buy
10,053
+2,019
+25% +$145K ﹤0.01% 2156
2025
Q1
$561K Sell
8,034
-290
-3% -$20.1K ﹤0.01% 2320
2024
Q4
$509K Buy
8,324
+1,242
+18% +$81.2K ﹤0.01% 2416
2024
Q3
$420K Buy
7,082
+898
+15% +$49.3K ﹤0.01% 2548
2024
Q2
$352K Buy
6,184
+464
+8% +$28.5K ﹤0.01% 2575
2024
Q1
$353K Sell
5,720
-150
-3% -$8.65K ﹤0.01% 2573
2023
Q4
$280K Buy
+5,870
New +$238K ﹤0.01% 2649
2023
Q2
Sell
-8,129
Closed -$211K 3255
2023
Q1
$211K Sell
8,129
-208
-2% -$5.63K ﹤0.01% 2778
2022
Q4
$217K Buy
+8,337
New +$228K ﹤0.01% 2688
2022
Q1
Sell
-7,373
Closed -$235K 3259
2021
Q4
$235K Buy
+7,373
New +$253K ﹤0.01% 2741
2019
Q1
Sell
-6,164
Closed -$256K 2324
2018
Q4
$256K Buy
6,164
+378
+7% +$15.6K ﹤0.01% 1766
2018
Q3
$247K Sell
5,786
-2,912
-33% -$154K ﹤0.01% 1920
2018
Q2
$449K Buy
8,698
+1,570
+22% +$86.3K ﹤0.01% 1458
2018
Q1
$350K Sell
7,128
-3,480
-33% -$138K ﹤0.01% 1560
2017
Q4
$374K Buy
+10,608
New +$321K ﹤0.01% 1496

Other funds holding NTNX

Cambridge Investment Research Advisors's NTNX Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Nutanix (NTNX) stake by 46% in Q2 2026, buying an estimated $191K and bringing the position to 13,489 shares worth $687K. The position accounts for ﹤0.01% of the portfolio, ranked #2658.

Cambridge Investment Research Advisors first reported a position in NTNX in Q4 2017 and has held it in 19 quarters since. The position peaked at $771K in Q3 2025. 188 funds tracked by Wall St. Rank hold NTNX as of Q2 2026.

  • Cambridge Investment Research Advisors held 13,489 shares of Nutanix worth $687K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 4,224 Nutanix shares in Q2 2026, an estimated $191K.
  • Nutanix made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2658 holding.
  • Cambridge Investment Research Advisors first reported a position in Nutanix in Q4 2017 and has held it in 19 quarters since.
  • Cambridge Investment Research Advisors's Nutanix position peaked at $771K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Nutanix as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.